Supply Ivermectin Powder CAS 70288-86-7

At present, China's veterinary drug API industry has shown a situation of a hundred flowers blooming and a hundred schools contending.
Entering the autumn, livestock and poultry began to gradually enter the stage of disease and difficult to keep. According to the characteristics and rules of disease epidemics each year, preventive drugs will gradually increase, which will lead to increased demand for some veterinary drugs in breeding.
According to experts, veterinary drugs can be roughly summarized into four categories: general disease prevention drugs; Drugs for the prevention and treatment of infectious diseases; Anti-parasitic diseases in vivo and in vitro; Other drugs. Among them, in addition to biochemical immune products for the prevention and control of infectious diseases (vaccine, vaccine, serum, antitoxin and toxoid, etc.), as well as special veterinary drugs such as livestock and poultry parasitic diseases and growth promotion drugs, the rest are the same as human drugs, but the dosage, dosage form and specifications are different, and have long been widely used to prevent and control livestock and poultry diseases. Among veterinary drugs, more than 20 kinds are commonly used, such as anaixin, amoxicillin, flufenicol, ceftiofur, oxytetracycline and colistin sulfate. Among the anti-parasitic drugs, in addition to the anti-helminthic drugs shared by humans and animals (mebendazole, levamisole, etc.), anti-schistosomiasis drugs (praziquantel, etc.), tapeworm drugs (niclosamide, etc.), anti-hepatic fluoriasis drugs for livestock and poultry (niclophene). Biochemical immune products are mainly used to prevent animal anthrax, brucellosis, glanders, salmonellosis, and a variety of viral infectious diseases. With the development of antibiotics and biochemical immunological products, many infectious diseases that harm animals have been basically controlled.
Like fluorfenicol in aminools, this raw material has become more and more resistant after more than a decade of rapid growth after the rapid chicken incident. Its market usage has begun to "rise and fall" at the end of 2022, and under the cost pressure of the livestock industry, farmers are more willing to use compound flufenicol, compound amoxicillin and other highly sensitive and efficient drugs to replace flufenicol. This has led to a low market price for the API, but in the past two years, the price of flufenicol has gradually begun to double or even triple.
Shock adjustment, the market wait-and-see atmosphere is strong, and the supply of multiple brand products is sufficient.